Acquisition and Issue of Consideration Shares

22 January 2016

Assura plc

Acquisition and Issue of Consideration Shares

Assura plc ("Assura"), the UK REIT and leading primary care property investor and developer announces that on 21 January 2016, it acquired Malmesbury Medical Enterprise Limited from its former shareholders Kate Badcock, David Charles, Angela Charles, Nigel Pickering, Janet Pickering, John Pettit, Philippa Pettit, Jaqueline Neale, John Harrison, Pamela Harrison, Thomas Estcourt, Sonia Munnelly & David Grogan (together, the "Sellers"). As part of the consideration payable under the terms of the acquisition, Assura has agreed to issue to the Sellers 876,222 ordinary shares of 10 pence each ("Ordinary Shares"). These new shares will rank pari passu with the existing Ordinary Shares.

Application has been made to the UK Listing Authority and to the London Stock Exchange for the new shares to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will occur at 8.00 a.m. on 27 January 2016. Based on the closing share price on 20 January 2016 of 52.6 pence per share, the new shares issued are valued at £0.5 million.

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission on 27 January 2016 will consist of 1,637,706,738 Ordinary Shares. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

For more information, please contact:

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2015, Assura's property portfolio was valued at £1,030 million.

Further information is available at www.assuraplc.com